novel
seri
diethyl
de
yl
methyl
alkylphosphon
design
analogu
amonafid
synthes
phosphon
assess
antivir
activ
broad
rang
dna
rna
virus
sever
show
potenc
varicellazost
viru
vzv
ec
effect
concentr
compound
exhibit
highest
activ
thymidin
kinasedefici
tk
vzv
strain
ec
potent
toward
tk
vzv
ec
cytostat
properti
compound
studi
cem
hela
cell
line
slightli
cytostat
hela
ic
inhibitori
concentr
cell
ic
inhibitori
concentr
pharmacolog
import
natur
well
synthet
compound
variou
heterocycl
system
includ
power
pharmacophor
triazol
naphthalimid
special
interest
numer
compound
famili
shown
broad
spectrum
biolog
activ
includ
antibacteri
antifung
anticanc
antivir
antiallerg
effect
furthermor
substitut
also
use
agrochem
dye
photostabilis
corros
inhibitor
variou
biolog
activ
substitut
close
relat
chemic
reactiv
sinc
abl
form
hydrogen
bond
could
proton
physiolog
ph
resist
oxid
reduct
well
enzymat
hydrolysi
name
import
featur
naphthalimid
deriv
mitonafid
amonafid
azonafid
elinafid
exhibit
intercal
properti
howev
clinic
use
compound
limit
due
low
therapeut
indic
well
poor
watersolubl
order
improv
therapeut
properti
naphthalimid
mani
effort
undertaken
toward
synthes
novel
deriv
higher
activ
lower
toxic
concept
combin
two
pharmacophor
fragment
biolog
activ
compound
singl
molecul
commonli
appli
aim
improv
activ
eventu
avoid
seriou
side
effect
known
candid
idea
mind
sever
structur
analogu
amonafid
synthes
year
figur
qian
li
report
synthesi
prove
cytotox
activ
furthermor
analogu
also
obtain
cytotox
hela
cell
evalu
among
test
compound
deriv
n
ndimethylamino
ethyl
group
imid
nitrogen
phenyl
ring
altern
lack
substitu
found
activ
rang
inhibit
abil
higher
amonafid
use
control
hand
antifung
antimicrobi
properti
deriv
examin
sever
compound
exhibit
even
better
activ
test
strain
orbifloxacin
chloromycin
fluconazol
use
refer
drug
among
bi
conjug
naphthalimid
deriv
substitut
group
exhibit
better
inhibitori
activ
toward
escherichia
coli
norfloxacin
chloromycin
minimum
inhibitori
concentr
mic
valu
achiev
prompt
us
propos
new
modif
imid
nitrogen
amonafid
instal
decor
end
alkyl
chain
phosphonoalkyl
group
aim
understand
influenc
phosphon
group
biolog
activ
design
amonafid
analogu
hand
compound
resembl
analogu
acycl
nucleotid
phosphat
group
replac
phosphon
moieti
naphthalimid
fragment
serv
modifi
nucleobas
thu
principl
compound
may
primarili
act
intercal
naphthalimid
ring
also
phosphon
activ
termin
dnarna
synthesi
qian
li
report
synthesi
prove
cytotox
activ
furthermor
analogu
also
obtain
cytotox
hela
cell
evalu
among
test
compound
deriv
n
ndimethylamino
ethyl
group
imid
nitrogen
phenyl
ring
altern
lack
substitu
found
activ
ic
rang
inhibit
abil
higher
amonafid
use
control
hand
antifung
antimicrobi
properti
deriv
examin
sever
compound
exhibit
even
better
activ
test
strain
orbifloxacin
chloromycin
fluconazol
use
refer
drug
among
bi
conjug
naphthalimid
deriv
substitut
group
exhibit
better
inhibitori
activ
toward
escherichia
coli
norfloxacin
chloromycin
minimum
inhibitori
concentr
mic
valu
achiev
prompt
us
propos
new
modif
imid
nitrogen
amonafid
instal
decor
end
alkyl
chain
phosphonoalkyl
group
aim
understand
influenc
phosphon
group
biolog
activ
design
amonafid
analogu
hand
compound
resembl
analogu
acycl
nucleotid
phosphat
group
replac
phosphon
moieti
naphthalimid
fragment
serv
modifi
nucleobas
thu
principl
compound
may
primarili
act
intercal
naphthalimid
ring
also
phosphon
activ
termin
dnarna
synthesi
synthet
strategi
naphthalimid
deriv
present
scheme
synthes
alkyn
previous
describ
purpos
project
obtain
follow
known
procedur
describ
although
appear
new
approach
prepar
compound
alkyn
synthes
commerci
avail
anhydrid
shown
scheme
nitrat
anhydrid
provid
reduc
give
compound
subsequ
propargyl
afford
alkyn
respect
azidophosphon
previous
obtain
fulli
character
laboratori
cu
catalyz
dipolar
cycloaddit
npropargyl
deriv
respect
azidoalkylphosphon
allow
construct
naphthalimid
variou
phosphonoalkyl
group
regioselect
instal
subunit
scheme
chromatograph
purif
crystal
gave
pure
good
excel
yield
structur
puriti
establish
h
cand
pnmr
ir
techniqu
well
element
analys
synthet
strategi
naphthalimid
deriv
present
scheme
synthes
alkyn
previous
describ
purpos
project
obtain
follow
known
procedur
describ
although
appear
new
approach
prepar
compound
alkyn
synthes
commerci
avail
anhydrid
shown
scheme
nitrat
anhydrid
provid
reduc
give
compound
subsequ
propargyl
afford
alkyn
respect
azidophosphon
previous
obtain
fulli
character
laboratori
cu
catalyz
dipolar
cycloaddit
npropargyl
deriv
respect
azidoalkylphosphon
allow
construct
naphthalimid
variou
phosphonoalkyl
group
regioselect
instal
subunit
scheme
chromatograph
purif
crystal
gave
pure
good
excel
yield
structur
puriti
establish
h
synthet
strategi
naphthalimid
deriv
present
scheme
synthes
alkyn
previous
describ
purpos
project
obtain
follow
known
procedur
describ
although
appear
new
approach
prepar
compound
alkyn
synthes
commerci
avail
anhydrid
shown
scheme
nitrat
anhydrid
provid
reduc
give
compound
subsequ
propargyl
afford
alkyn
respect
azidophosphon
previous
obtain
fulli
character
laboratori
cu
catalyz
dipolar
cycloaddit
npropargyl
deriv
respect
azidoalkylphosphon
allow
construct
naphthalimid
variou
phosphonoalkyl
group
regioselect
instal
subunit
scheme
chromatograph
purif
crystal
gave
pure
good
excel
yield
structur
puriti
establish
h
phosphon
evalu
antivir
activ
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
human
embryon
lung
hel
cell
cultur
herp
simplex
ko
strain
herp
simplex
g
strain
vaccinia
viru
vesicular
stomat
viru
thymidin
kinasedefici
herp
simplex
tk
ko
acv
r
adenoviru
hippeastrum
hybrid
agglutinin
hha
urticadioica
agglutinin
uda
dextran
sulfat
molecular
weight
ribavirin
oseltamivir
carboxyl
amantadin
rimantadin
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
virus
among
synthes
compound
sever
phosphon
slightli
inhibit
replic
tk
tk
vzv
strain
ec
rang
howev
lower
potenc
acyclovir
brivudin
use
refer
drug
tabl
cytotox
test
compound
toward
uninfect
host
cell
defin
minimum
cytotox
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
cytotox
concentr
cc
caus
decreas
cell
viabil
determin
use
colorimetr
mt
assay
system
none
test
compound
affect
cell
morpholog
hel
hela
vero
mdck
crfk
cell
concentr
cytostat
activ
test
compound
defin
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
murin
leukaemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
human
dermal
microvascular
endotheli
cell
tabl
tabl
inhibitori
effect
test
compound
prolifer
murin
leukemia
human
tlymphocyt
cem
human
cervix
carcinoma
cell
hela
ic
among
test
compound
conjug
bromin
atom
naphthalimid
unit
cystostat
toward
test
tumor
cell
line
concentr
low
especi
effect
ic
conjug
contain
nitro
group
slightli
less
activ
show
moder
cytostat
effect
toward
hela
cell
ic
replac
nitro
amino
group
naphthalimid
skeleton
result
decreas
even
loss
inhibitori
capac
respect
analogu
vs
similarli
neglig
inhibitori
properti
prolifer
test
cell
line
notic
seri
naphthalimid
phosphon
r
h
presenc
unit
seem
necessari
cytostat
activ
test
compound
sinc
naphthalimid
devoid
moieti
appear
inact
vs
vs
howev
found
compound
moder
inhibit
ic
prolifer
hela
cell
naphthalimid
could
consid
inact
ic
among
phosphon
linker
compound
nitro
bromo
compound
longer
fragment
gener
associ
higher
potenc
eg
trimethylen
tetramethylen
ch
ch
och
ch
lowest
activ
observ
ch
oh
ch
well
ch
nhc
ch
shorter
fragment
follow
adsorb
use
column
chromatographi
silica
gel
mesh
merck
kgaa
darmstadt
germani
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
tlc
plate
develop
chloroformmethanol
solvent
system
visual
spot
effect
iodin
vapor
solvent
purifi
method
describ
literatur
microwav
irradi
experi
carri
rm
microwav
reactor
plazmatronika
poland
suspens
compound
mmol
propargyl
amin
mmol
ethanol
ml
stir
c
h
reaction
mixtur
cool
room
temperatur
filter
give
pure
de
dion
suspens
compound
mmol
propargyl
amin
mmol
ethanol
ml
stir
c
h
reaction
mixtur
cool
room
temperatur
filter
give
orang
powder
pure
use
next
step
without
purif
suspens
compound
mmol
propargyl
amin
mmol
ethanol
ml
stir
c
h
reaction
mixtur
cool
room
temperatur
filter
give
orang
needl
pure
use
next
step
without
purif
yield
mp
de
dion
compound
evalu
follow
virus
herp
simplex
viru
type
strain
ko
thymidin
kinasedefici
tk
ko
strain
resist
acv
acv
r
herp
simplex
viru
type
strain
lyon
g
varicellazost
viru
vzv
strain
oka
tk
vzv
strain
human
cytomegaloviru
hcmv
strain
davi
vaccinia
viru
lederl
strain
respiratori
syncyti
viru
rsv
strain
long
vesicular
stomat
viru
vsv
coxsacki
parainfluenza
influenza
viru
subtyp
influenza
viru
b
sindbi
punta
toro
human
immunodefici
viru
type
strain
iii
b
human
immunodefici
viru
type
strain
rod
antivir
antihiv
assay
base
inhibit
virusinduc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
cell
vero
human
epitheli
cell
hela
madindarbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
vzv
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
viral
plaqu
format
assay
perform
microtit
plate
well
ad
tumor
cell
given
amount
test
compound
cell
allow
prolifer
h
murin
leukemia
cell
h
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
c
humidifi
co
control
atmospher
end
incub
period
cell
count
coulter
counter
ic
inhibitori
concentr
defin
concentr
compound
inhibit
cell
prolifer
novel
seri
diethyl
de
yl
methyl
alkylphosphon
synthes
good
excel
yield
via
cu
catalyz
dipolar
cycloaddit
npropargyl
naphthalimid
respect
azidoalkylphosphon
microwav
irradi
synthes
phosphon
evalu
varieti
dna
rna
virus
sever
appear
slightli
activ
vzv
ec
among
compound
show
potenc
toward
tk
vzv
strain
found
activ
tk
vzv
strain
ec
ec
valu
compar
refer
drug
hand
compound
exhibit
highest
activ
tk
vzv
ec
athough
lower
refer
compound
cytostat
properti
compound
studi
cem
hela
cell
line
slightli
cytostat
hela
ic
cell
ic
among
test
compound
deriv
substitut
bromin
atom
activ
base
preliminari
sar
analysi
establish
presenc
unit
essenti
cytostat
activ
furthermor
compound
longer
linker
ch
ch
ch
ch
och
ch
show
higher
cytostat
potenc
shorter
fragment
ch
oh
ch
ch
nhc
ch
